Logo image of CLMT

CALUMET INC (CLMT) Stock Fundamental Analysis

NASDAQ:CLMT - Nasdaq - US1314281049 - Common Stock - Currency: USD

16.34  +0.8 (+5.15%)

After market: 16.34 0 (0%)

Fundamental Rating

1

Taking everything into account, CLMT scores 1 out of 10 in our fundamental rating. CLMT was compared to 211 industry peers in the Oil, Gas & Consumable Fuels industry. Both the profitability and financial health of CLMT have multiple concerns. CLMT is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year CLMT has reported negative net income.
CLMT had a negative operating cash flow in the past year.
CLMT had negative earnings in 4 of the past 5 years.
In multiple years CLMT reported negative operating cash flow during the last 5 years.
CLMT Yearly Net Income VS EBIT VS OCF VS FCFCLMT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

1.2 Ratios

Looking at the Return On Assets, with a value of -13.60%, CLMT is doing worse than 88.15% of the companies in the same industry.
Industry RankSector Rank
ROA -13.6%
ROE N/A
ROIC N/A
ROA(3y)-4.08%
ROA(5y)-6.46%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CLMT Yearly ROA, ROE, ROICCLMT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100

1.3 Margins

In the last couple of years the Operating Margin of CLMT has declined.
The Gross Margin of CLMT (2.88%) is worse than 76.30% of its industry peers.
CLMT's Gross Margin has declined in the last couple of years.
CLMT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 2.88%
OM growth 3YN/A
OM growth 5Y-41.55%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.67%
GM growth 5Y-15.88%
CLMT Yearly Profit, Operating, Gross MarginsCLMT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10

More info and screens

1

2. Health

2.1 Basic Checks

CLMT does not have a ROIC to compare to the WACC, probably because it is not profitable.
CLMT has more shares outstanding than it did 1 year ago.
The number of shares outstanding for CLMT has been increased compared to 5 years ago.
CLMT has a worse debt/assets ratio than last year.
CLMT Yearly Shares OutstandingCLMT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
CLMT Yearly Total Debt VS Total AssetsCLMT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

CLMT has an Altman-Z score of 1.13. This is a bad value and indicates that CLMT is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.13, CLMT is in line with its industry, outperforming 46.92% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 1.13
ROIC/WACCN/A
WACC10.42%
CLMT Yearly LT Debt VS Equity VS FCFCLMT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B 2B

2.3 Liquidity

CLMT has a Current Ratio of 1.06. This is a normal value and indicates that CLMT is financially healthy and should not expect problems in meeting its short term obligations.
CLMT has a Current ratio (1.06) which is comparable to the rest of the industry.
A Quick Ratio of 0.61 indicates that CLMT may have some problems paying its short term obligations.
CLMT has a Quick ratio of 0.61. This is in the lower half of the industry: CLMT underperforms 73.93% of its industry peers.
Industry RankSector Rank
Current Ratio 1.06
Quick Ratio 0.61
CLMT Yearly Current Assets VS Current LiabilitesCLMT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

4

3. Growth

3.1 Past

CLMT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -6642.86%.
Looking at the last year, CLMT shows a very strong growth in Revenue. The Revenue has grown by 24.90%.
The Revenue has been growing slightly by 3.94% on average over the past years.
EPS 1Y (TTM)-6642.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-407.84%
Revenue 1Y (TTM)24.9%
Revenue growth 3Y9.99%
Revenue growth 5Y3.94%
Sales Q2Q%-1.18%

3.2 Future

The Earnings Per Share is expected to grow by 29.17% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 7.25% on average over the next years.
EPS Next Y12.2%
EPS Next 2Y42.12%
EPS Next 3Y28.42%
EPS Next 5Y29.17%
Revenue Next Year-3.72%
Revenue Next 2Y-2.77%
Revenue Next 3Y1.23%
Revenue Next 5Y7.25%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CLMT Yearly Revenue VS EstimatesCLMT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2B 4B 6B
CLMT Yearly EPS VS EstimatesCLMT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 -2 4 -4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CLMT. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 311.48 indicates a quite expensive valuation of CLMT.
CLMT's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. CLMT is more expensive than 70.62% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 21.76. CLMT is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 311.48
CLMT Price Earnings VS Forward Price EarningsCLMT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 100 200 300

4.2 Price Multiples

74.41% of the companies in the same industry are cheaper than CLMT, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 82.59
CLMT Per share dataCLMT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as CLMT's earnings are expected to grow with 28.42% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y42.12%
EPS Next 3Y28.42%

More info and screens

0

5. Dividend

5.1 Amount

CLMT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CALUMET INC

NASDAQ:CLMT (7/2/2025, 8:26:50 PM)

After market: 16.34 0 (0%)

16.34

+0.8 (+5.15%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)05-09 2025-05-09/bmo
Earnings (Next)08-07 2025-08-07
Inst Owners46.21%
Inst Owner Change6.41%
Ins Owners3.14%
Ins Owner Change0.8%
Market Cap1.42B
Analysts78.46
Price Target20.4 (24.85%)
Short Float %12.49%
Short Ratio7.16
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-158.08%
Min EPS beat(2)-346.52%
Max EPS beat(2)30.36%
EPS beat(4)2
Avg EPS beat(4)-89.27%
Min EPS beat(4)-346.52%
Max EPS beat(4)30.36%
EPS beat(8)4
Avg EPS beat(8)76.92%
EPS beat(12)5
Avg EPS beat(12)-483.8%
EPS beat(16)7
Avg EPS beat(16)-347.91%
Revenue beat(2)2
Avg Revenue beat(2)5.15%
Min Revenue beat(2)0.99%
Max Revenue beat(2)9.31%
Revenue beat(4)4
Avg Revenue beat(4)8.63%
Min Revenue beat(4)0.99%
Max Revenue beat(4)13.26%
Revenue beat(8)7
Avg Revenue beat(8)7.42%
Revenue beat(12)11
Avg Revenue beat(12)9.08%
Revenue beat(16)15
Avg Revenue beat(16)11.52%
PT rev (1m)-2.44%
PT rev (3m)-22.33%
EPS NQ rev (1m)-20.43%
EPS NQ rev (3m)-98.7%
EPS NY rev (1m)-80.12%
EPS NY rev (3m)-6041.89%
Revenue NQ rev (1m)-0.09%
Revenue NQ rev (3m)12.19%
Revenue NY rev (1m)6.53%
Revenue NY rev (3m)0.22%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 311.48
P/S 0.27
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 82.59
EPS(TTM)-4.72
EYN/A
EPS(NY)0.05
Fwd EY0.32%
FCF(TTM)-1.59
FCFYN/A
OCF(TTM)-0.73
OCFYN/A
SpS59.84
BVpS-9.95
TBVpS-9.95
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -13.6%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 2.88%
FCFM N/A
ROA(3y)-4.08%
ROA(5y)-6.46%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.9%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5Y-41.55%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.67%
GM growth 5Y-15.88%
F-Score3
Asset Turnover1.84
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 47.76
Cap/Depr 49.87%
Cap/Sales 1.43%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.06
Quick Ratio 0.61
Altman-Z 1.13
F-Score3
WACC10.42%
ROIC/WACCN/A
Cap/Depr(3y)260.7%
Cap/Depr(5y)180.19%
Cap/Sales(3y)6.59%
Cap/Sales(5y)4.87%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-6642.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-407.84%
EPS Next Y12.2%
EPS Next 2Y42.12%
EPS Next 3Y28.42%
EPS Next 5Y29.17%
Revenue 1Y (TTM)24.9%
Revenue growth 3Y9.99%
Revenue growth 5Y3.94%
Sales Q2Q%-1.18%
Revenue Next Year-3.72%
Revenue Next 2Y-2.77%
Revenue Next 3Y1.23%
Revenue Next 5Y7.25%
EBIT growth 1Y-138.21%
EBIT growth 3YN/A
EBIT growth 5Y-39.24%
EBIT Next Year3176.38%
EBIT Next 3Y277.46%
EBIT Next 5Y146.58%
FCF growth 1Y73.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-182.03%
OCF growth 3YN/A
OCF growth 5YN/A